Thomas Schmidt, MD

Original Contribution

Evaluation of a New Polymer-Coated Paclitaxel-Eluting Stent
for Treatment of De Novo Lesions: Six-Month Clinical and Angiograph

08/01/2008

Ulrich Gerckens , MD;

Victor Lim , MD;

Ralf Mueller , MD;

Thomas Schmidt , MD;

Lutz Buellesfeld , MD;

Eberhard Grube , MD;

In-stent restenosis as a result of excessive neointimal proliferation is the main limiting factor to the long-term success of coronary stenting, but the advent of drug-eluting stents has reduced this problem significantly. Paclitaxel is an...

In-stent restenosis as a result...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Thomas Schmidt, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products